tradingkey.logo
搜尋

Q C Technologies Ord Shs

QCLS
添加自選
3.960USD
+0.060+1.54%
收盤 07/01, 16:00美東報價延遲15分鐘
30.63M總市值
0.14本益比TTM

關於 公司

Q C Technologies Ord Shs簡介

公司代碼- -
公司名稱- -
上市日期- -
CEO- -
員工數量- -
證券類型- -
年結日- -
公司地址- -
城市- -
上市交易所- -
國家- -
郵編- -
電話- -
網址- -
公司代碼- -
上市日期- -
CEO- -

Q C Technologies Ord Shs公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Christopher C. Schreiber
Mr. Christopher C. Schreiber
Director
Director
27.19K
+91.94%
Mr. Stephen Friscia
Mr. Stephen Friscia
Independent Director
Independent Director
25.00K
-8.64%
Dr. Mitchell Glass, M.D.
Dr. Mitchell Glass, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
12.50K
-8.64%
Mr. Bill Joe White
Mr. Bill Joe White
Independent Director
Independent Director
--
--
Mr. Joshua N. (Josh) Silverman
Mr. Joshua N. (Josh) Silverman
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Ian Rhodes
Mr. Ian Rhodes
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--
Mr. Robert Schatz
Mr. Robert Schatz
Investor Relations
Investor Relations
--
--
Mr. Bruce Bernstein
Mr. Bruce Bernstein
Director
Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Christopher C. Schreiber
Mr. Christopher C. Schreiber
Director
Director
27.19K
+91.94%
Mr. Stephen Friscia
Mr. Stephen Friscia
Independent Director
Independent Director
25.00K
-8.64%
Dr. Mitchell Glass, M.D.
Dr. Mitchell Glass, M.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
12.50K
-8.64%
Mr. Bill Joe White
Mr. Bill Joe White
Independent Director
Independent Director
--
--
Mr. Joshua N. (Josh) Silverman
Mr. Joshua N. (Josh) Silverman
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Ian Rhodes
Mr. Ian Rhodes
Interim Chief Financial Officer
Interim Chief Financial Officer
--
--

常見問題

Q C Technologies Ord Shs的前五大股東是誰?

Q C Technologies Ord Shs的前五大股東如下:Mr. Christopher C. Schreiber

哪個業務部門對Q C Technologies Ord Shs的收入貢獻最大?

在2026Q4,Particle ImmunoFiltration Assay (“PIFA”)業務部門對Q C Technologies Ord Shs的收入貢獻最大,創收1.33M,占總收入的84.19% 。